PROTECTIVE EFFECT OF SULODEXIDE IN COVID-19 INFECTION
The article provides data indicating that the drug sulodexid, which is a mixture of the rapid fraction of heparin and dermatan sulfate, is able to significantly reduce endothelial damage and the degree of thrombus formation in patients with coronavirus infection COVID-19, which facilitates the course of the disease and helps to improve its outcome.